Pete Yehl is an Executive Director and Department Head of Small Molecule Analytical Chemistry at Genentech, where they lead a team of 75 analytical scientists and manage a $20 million annual budget. With 25 years of experience in CMC drug development, they have previously held leadership roles at Merck and PTC Therapeutics, directing analytical support across various drug development stages. Yehl holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst, and a Bachelor's degree in Manufacturing Engineering from the Rochester Institute of Technology.
This person is not in any teams
This person is not in any offices